A Step Towards a Type I Diabetes Vaccine by Using Nanotherapy
June 11, 2015
(Nanotechnology Now) – Two years ago, the Immunology of Diabetes Research Group at the Germans Trias Research Institute (at Universitat Autònoma de Barcelona – Campus of International Excellence Sphere) reported a new experimental immunotherapy that prevented the onset of Type 1 Diabetes in mice predisposed to the disease. This work led to more studies with the support of the Spanish Government, Catalan Government and private patrons with a keen interest in it. Thanks to this, the article published today in PLOS ONE describes a new step towards the creation of a vaccine, which in the medium-term could be capable of preventing and even curing the disease in humans.